Fig. 3From: Coacervate-mediated novel pancreatic cancer drug Aleuria Aurantia lectin delivery for augmented anticancer therapyBiocompatibility of AAL to normal pancreas cell H6C7 and AAL concentration-dependent anticancer efficacyBack to article page